TIMP1 and prostate carcinoma: In prostate cancer, NR2C2 could prevent or delay prostate tumorigenesis via regulating the ATM expression at the transcriptional level and could suppress prostate cancer invasion via altering the TIMP-1/MMP2/MMP9 signals (17, 35).